Skip to main content
Home
FDA
  • LOG IN
  • Thompson FDA
  • Manage Account
  •  
  • 1.800.677.3789

Main navigation

  • LIBRARY
    • FDA Enforcement Manual
    • Guide to Good Clinical Practice
    • FDA Advertising and Promotion Manual
    • Guide to Medical Device Regulation
    • Guide to U.S. Food Labeling Law
  • MY RESEARCH
  • NEWS
    • All News
    • FDA Intelligence
  • DATABASES
    • FDA Enforcement Database
    • Clinlaw State Database
  • RESOURCES
    • FDA Forms
    • Special Reports
    • Judicial Opinions
    • Interactive Tools
  • AGENCY GUIDANCE
    • Enforcement Guidance
    • Clinical Trials Guidance
    • Advertising and Promotion Guidance
    • Medical Device Guidance
    • Food Labeling Guidance
  • ASK THE EXPERT

Login to the Thompson
FDA Compliance Expert

Enter your FDA username.
Enter the password that accompanies your username.
Forgot password?

Questions? Give us a call! 1-800-677-3789

Advertising & Promotion

  • May 10, 2018
    30 Calif. Counties Announce Opioid Lawsuits
  • May 10, 2018
    NAD Recommends Challenged Claims for Cold Sore Treatment Be Discontinued
  • May 9, 2018
    MHRA Issues Two Promotion Rulings
  • May 8, 2018
    Tenn. Governor Signs Bill Allowing Truthful Promotion of Off-label Uses
  • May 3, 2018
    Physician Found Guilty of HIPAA Violation in Marketing Case
  • May 2, 2018
    District Court Allows Kickback Case to Proceed
  • Apr 29, 2018
    Teamsters Sue Opioid Manufacturers
  • Apr 27, 2018
    NAD Refers Claims to FDA, FTC
  • Apr 26, 2018
    Minnesota Congressman Mulls Bill To Ban Opioid Ads
  • Apr 23, 2018
    USITC Launches Investigation of Clidinium Bromide Products
  • More

Good Clinical Practice

  • Aug 16, 2018
    Studies Find Only One-Third of Researchers Declare COI in Journal Articles
  • Aug 13, 2018
    Groups Propose FDA Guidance on Cancer Trial Eligibility Criteria
  • Aug 13, 2018
    FDA Draft Guidance Details FIH Multiple Cohort Trials
  • Aug 13, 2018
    FDA Sets October Workshop for Development of Patient-Focused Guidance
  • Aug 10, 2018
    U.S. Rep., Two Others Charged with Insider Trading Over Disclosure of Negative Trial Results
  • Aug 10, 2018
    Workshop Considers Subpopulations
  • Aug 8, 2018
    EC Releases Draft GCP Guidelines for Advanced Therapies
  • Aug 6, 2018
    FDA Suggests Additional Endpoint for OUD Trials
  • Aug 3, 2018
    EMA Clarifies Role and Need for DMCs
  • Jul 31, 2018
    CTTI Releases Road Map for Using Mobile Technologies in Clinical Trials
  • More

U.S. Food Labeling

  • Dec 26,2013
    FSIS Advisory Committee To Meet Jan. 7-8 To Discuss Changes to Safe Handling Instructions
  • Dec 17,2013
    USDA: No More Additions to Food Labeling Compendium
  • Dec 17,2013
    FSIS Rule Change To Expand Generic Approval Program for Meats and Poultry Starting Jan. 6
  • Dec 13,2013
    House Bill Pushes New Labeling Requirements Removing Loophole for Foods Low in Trans Fats
  • Dec 12,2013
    Better Late Than Never; Conn. Governor Holds Signing Ceremony for GMO Bill Approved in June
  • Nov 18,2013
    Speaker: Unsupported Health Claims At Risk of Drawing Class Action Suits
  • Nov 15,2013
    Washington State Ballot Results Show Voters Rejected I-522 in Close Election
  • Nov 15,2013
    Comment Period Reopened on Planned Restrictions to Medical Food Labeling
  • Nov 13,2013
    Trade Group Documents Outline Plans To Kill State GMO Labeling Efforts, Push Federal Preemption
  • Nov 8,2013
    Cargill Plans Disclosure Label for Ground Beef Products Containing ‘Pink Slime’ Additive
  • More

FDA Regulation & Enforcement

  • Jul 8, 2021
    USDA Commits to Wholesale Review of ‘Product of USA’ Labeling
  • Jul 2, 2021
    J&J Reaches Settlement with New York Over Opioids
  • Jun 30, 2021
    HHS OIG: Device Maker’s Discount Program for Hospitals Would Not Raise Health Care Fraud Concerns
  • Jun 26, 2021
    OPDP Continues Study of Unapproved Use Data
  • Jun 24, 2021
    DOJ Obtains Guilty Pleas from Individuals, Supplement Companies on Charges of Distributing Steroids
  • Jun 23, 2021
    FDA Updates Standard of Identity for Yogurt Products
  • Jun 21, 2021
    GAO Finds DTC Ads May Be Factor in Medicare Costs
  • Jun 16, 2021
    Generic Drug Maker, Two Executives Indicted for Allegedly Deceiving FDA About Sourcing of API
  • Jun 15, 2021
    NOSB Will Meet in October
  • Jun 13, 2021
    OPDP Researchers To Examine Accelerated Approval Disclosures on DTC Websites
  • More

Medical Devices

  • Aug 8, 2016
    FDA Releases Draft Guidance on When Device Modifications Trigger 510(k) Requirement
  • Aug 3, 2016
    DOJ Charges Device Development Company, Owner with Fraud in Connection with Three NIH Grants
  • Aug 1, 2016
    FDA’s Medical Device User Fees To Drop in Fiscal Year 2017
  • Jul 29, 2016
    Device Center Highlights EFS Considerations
  • Jul 28, 2016
    FDA-CMS Looking to Simplify Device Coverage
  • Jul 28, 2016
    FDA Softens Device Adaptive Design Guidance
  • Jul 27, 2016
    Acclarent Resolves False Claims Charges Related to Alleged Off-label Marketing for $18 Million
  • Jul 26, 2016
    Draft Guidance Covers Form, Content Issues Involved with Unique Device Identifiers
  • Jul 21, 2016
    FDA Issues Draft Guidance on Codevelopment of Therapeutic Products, Companion Diagnostics
  • Jul 11, 2016
    Draft Guidance Documents on NGS-Based Tests Seek ‘Dynamic and Flexible’ Regulatory Pathway
  • More

THOMPSON FDA

  • Thompson FDA
  • About Us
  • Manage Account
  • Our Parent Company

COMPLIANCE EXPERT

  • News
  • My Research
  • Our Experts
  •  

RESOURCES

  • FDA Forms
  • Special Reports

HELP

  • Customer Support
  •  
  •  
  •  
  •  

CONTACT

  • headquarter Headquarters
  • contact-number 1.800.677.3789
  • Contact Us
  •  

Copyright © Thompson FDA, a division of CBIS. All rights reserved.

  • Terms
  • Privacy

FDA NEWS
YOU CAN USE

Get instant, free access to the latest news and analysis to keep up with the shifting requirements, recommendations, and expectations of the FDA.

Something went wrong. Please try after some time.